Ö. SÖNMEZLER Et Al. , "CRISPR-Cas9 mediated knockdown of PIK3CA to restore the therapeutic response via apoptotic pathway in breast cancer," European and British Society of Gene and Cell Therapy Congress 2022 , 2022
SÖNMEZLER, Ö. Et Al. 2022. CRISPR-Cas9 mediated knockdown of PIK3CA to restore the therapeutic response via apoptotic pathway in breast cancer. European and British Society of Gene and Cell Therapy Congress 2022 .
SÖNMEZLER, Ö., MÜJDE, C., BOGA, İ., & BİŞGİN, A., (2022). CRISPR-Cas9 mediated knockdown of PIK3CA to restore the therapeutic response via apoptotic pathway in breast cancer . European and British Society of Gene and Cell Therapy Congress 2022
SÖNMEZLER, ÖZGE Et Al. "CRISPR-Cas9 mediated knockdown of PIK3CA to restore the therapeutic response via apoptotic pathway in breast cancer," European and British Society of Gene and Cell Therapy Congress 2022, 2022
SÖNMEZLER, ÖZGE Et Al. "CRISPR-Cas9 mediated knockdown of PIK3CA to restore the therapeutic response via apoptotic pathway in breast cancer." European and British Society of Gene and Cell Therapy Congress 2022 , 2022
SÖNMEZLER, Ö. Et Al. (2022) . "CRISPR-Cas9 mediated knockdown of PIK3CA to restore the therapeutic response via apoptotic pathway in breast cancer." European and British Society of Gene and Cell Therapy Congress 2022 .
@conferencepaper{conferencepaper, author={ÖZGE SÖNMEZLER Et Al. }, title={CRISPR-Cas9 mediated knockdown of PIK3CA to restore the therapeutic response via apoptotic pathway in breast cancer}, congress name={European and British Society of Gene and Cell Therapy Congress 2022}, city={}, country={}, year={2022}}